Friday, June 22, 2007
Our Government Knows The TRUTH About Medicinal Marijuana...But Don't Give A Damn About Sick Americans
The University of Mississippi sends out seven cans of marijuana to seven patients across the country with an FDA stamp on it. For the last twenty nine years in this country the federal government has been, on every seventeenth of the month, been distributing canisters of medicinal marijuana to patients across the country. They started off with 21 [patients] and now it's down to seven, because they're the only people that have remained alive.
The longest surviving federal marijuana smoker in the United States,Irvin Rosenfeld,is alive and well.
It all began with Robert Randall who was diagnosed with severe glaucoma at age 24 and was expected to become totally blind long before he turned 30. He soon began a fascinating medical odyssey that has been memorialized in his “personal reflection” co-authored by his wife, Alice O’Leary, titled Marijuana Rx: The Patients’ Fight for Medicinal Pot (Randall and O’Leary 1998), and other books (Randall 1991a; Randall 1991b). Until the day he died on June 2, 2001 at age 52 of complications of AIDS, Randall retained his vision, and remained a vocal advocate for the benefits of clinical cannabis.
I personally believe the federal government and states includingTennessee (HB0486 and SB0641) wants to keep medicinal marijuana illegal is because of lobbyist for pharmaceutical companies. ONE prescription out of many multiple sclerosis patients take cost $1600.00 a month that totals $19,200.00 a year. You don't have to be a rocket scientist to know WHY pharmaceutical companies DO NOT want medicinal marijuana legalized.
7 surviving patients in the USA remain in the Compassionate IND program.
The Missoula Chronic Cannabis Use Study thus provides a unique and important opportunity to scrutinize the long-term effects of cannabis on patients who have used a known dosage of standardized, heat-sterilized quality-controlled supply of low-grade medical marijuana for 11 to 27 years.
The Missoula Chronic Cannbis Use Study CONCLUSIONS AND RECOMMENDATIONS:
1. Cannabis smoking, even of a crude, low-grade product, provides effective symptomatic relief of pain, muscle spasms, and intraocular pressure elevations in selected patients failing other modes of treatment.
2. These clinical cannabis patients are able to reduce or eliminate other prescription medicines and their accompanying side effects.
3. Clinical cannabis provides an improved quality of life in these patients.
4. The side effect profile of NIDA cannabis in chronic usage suggests some mild pulmonary risk.
5. No malignant deterioration has been observed.
6. No consistent or attributable neuropsychological or neurological deterioration has been observed.
7. No endocrine, hematological or immunological sequelae have been observed.
8. Improvements in a clinical cannabis program would include already and consistent supply of sterilized, potent, organically grown unfertilized female flowering top material, thoroughly cleaned of extraneous inert fibrous matter.
9. It is the authors’ opinion that the Compassionate IND program should be reopened and extended to other patients in need of clinical cannabis.
10. Failing that, local, state and federal laws might be amended to provide regulated and monitored clinical cannabis to suitable candidates.
Finally in 1992, critics charge President Bush #1 killed the program and I agree with the critics. Many Americans who suffer with chronic illness are suffering because Bush #1‘appealing to a few cultural zealots and we are still suffering today under President Bush #2